All-Cause Mortality Reduction Associated WIth Use of PDE5 Inhibitor in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Heart (British Cardiac Society)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated With a Reduction in All-Cause Mortality
Heart 2016 Jul 26;[EPub Ahead of Print], SG Anderson, DC Hutchings, M Woodward, K Rahimi, MK Rutter, M Kirby, G Hackett, AW Trafford, AH HealdFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.